IPA Europe appreciates the opportunity provided by EFSA to comment on EFSA guidance documents and scientific outputs of keen public interest.
IPA Europe welcomes the possibility offered by EFSA to share information, data and other feedback on scientific assessments and corporate initiatives. Also, we request to have more opportunities of dialogue between the applicant and EFSA prior to the submission of a health claim dossier.
IPA Europe comments to the EFSA consultation on its statement on “how to conduct and describe the whole genome sequence (WGS) based analysis of microorganisms used in the food chain”
28 February 2020
IPA Europe appreciates the opportunity to comment on the draft EFSA statement “The use of Whole Genome Sequencing in microbiology is expanding” and an EFSA Guidance for applicants will be both useful and timely. We encourage EFSA to balance very precise requirements against providing a certain window of freedom to choose methods and algorithms with a sufficient quality standard.
Election of new member and alternate member of EFSA’s stakeholder bureau
22 March 2019
EFSA has just announced the outcome of the election of the new Member and Alternate Member of EFSA’s Stakeholder Bureau.
We look forward to continuing the constructive discussions that are taking place with EFSA.
Meeting with the European Food Safety Authority (EFSA)
18 January 2019
IPA Europe met with the European Food Safety Authority (EFSA) in Parma, Italy, for a scientific discussion. This enabled IPA Europe’s scientific experts to gain a better understanding of the EFSA role and remit, particularly with regard to scientific substantiation of health claims made on food.
A debate also took place regarding the lack of a harmonized EU approach and the confusion this causes for consumers. It was clear from this exchange that there is an urgent need to ensure recognition of the probiotics category and to adopt a coherent, harmonized approach within the EU Single Market.
Comments by IPA Europe on the consultation document of “The Use of the Weight of Evidence Approach in Scientific Assessments”
28 April 2017
IPA Europe appreciates EFSA’s revision of “The Use of the Weight of Evidence Approach in Scientific Assessments”. Following the release of the previous document, however, IPAEU submitted several comments on fundamental points that should be addressed and re-considered.
Comments by IPA Europe on the consultation document “Guidance on Biological Relevance”
28 April 2017
The industry welcomes EFSA’s efforts to address the three most important key elements of the scientific assessment for Health claims (and / or Risk assessment): the analysis of ‘Uncertainty’, ‘Weight of Evidence’ and specifically, ‘Biological Relevance’. For the benefit of all parties involved in the submission and evaluation process, we highly recommend the introduction of pre-submission meetings.
IPA Europe comments on the revised EFSA Guidance documents
18 January 2016
The European Food Safety Authority (EFSA) published the revised guidance for health claims related to the immune system, the gastrointestinal tract and defense against pathogenic microorganisms and also the general scientific guidance on health claim applications. IPA Europe is happy to see that these documents clarify some questions and that the consultation procedure has therefore been productive. However, there are also still a number of points that IPA Europe believes have not been adequately considered.
IPA Europe comments on the EFSA Strategy 2020 – trusted science for safe food
20 November 2015
The International Probiotics Association (IPA) Europe welcomes the public consultation on EFSA‘s strategy for 2020 as it gives the opportunity to provide feedback on EFSA’s vision.
IPA Europe becomes an EFSA registred stakeholder
IPA Europe is now registered in the official list of EFSA’s stakeholders and looks forward to contributing to EFSA’s work plan and priorities.